المؤلفون: Viktor Grünwald, Daniel Pink, Gerlinde Egerer, Enrico Schalk, Marinela Augustin, Christoph K. W. Deinzer, Viola Kob, Dietmar Reichert, Maxim Kebenko, Stephan Brandl, Dennis Hahn, Lars H. Lindner, Mathias Hoiczyk, Uta Ringsdorf, Lars C. Hanker, Dirk Hempel, Beatriz De Rivas, Tobias Wismann, Philipp Ivanyi

المصدر: Cancers; Volume 14; Issue 21; Pages: 5234

مصطلحات موضوعية: trabectedin, STS, sarcoma, non-interventional, prospective, Cancer Research, Oncology, Medizin

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84365cacc06a13c5327a9b98c4b57a49
https://doi.org/10.3390/cancers14215234

المؤلفون: Maxim Kebenko, Dimosthenis Andreou, Sebastian Bauer, Peter Hohenberger, Stephan Richter, Lars H. Lindner, Peter Reichardt, Joanna Szkandera, Marietta Kirchner, Bernd Kasper, Daniel Pink, Thomas Brodowicz, Viktor Grünwald

المصدر: Cancers, Vol 13, Iss 1223, p 1223 (2021)
Cancers
Volume 13
Issue 6

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, efficacy, Medizin, lcsh:RC254-282, Pazopanib, 03 medical and health sciences, chemistry.chemical_compound, paclitaxel, 0302 clinical medicine, Internal medicine, medicine, Clinical endpoint, pazopanib, Angiosarcoma, 030212 general & internal medicine, Progression-free survival, Adverse effect, neoplasms, angiosarcoma, business.industry, toxicity, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Oncology, Paclitaxel, chemistry, 030220 oncology & carcinogenesis, Cohort, Sarcoma, business, progression-free survival, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b99d0f5d237f9f890a079cfab122a69
https://www.mdpi.com/2072-6694/13/6/1223

المؤلفون: Matthias Egger, Stephan Probst, Jörg Trojan, Alexander Reichart, Dirk M Behringer, Salah-Eddin Al-Batran, Volker Rethwisch, Michael Pohl, Gerald Illerhaus, Jan Stoehlmacher, Jörg Weniger, Daniel Pink, Wael Hozaeel, Rolf Mahlberg, Georg Martin Haag, Severin Daum, Carmen Löhr, Wolff Schmiegel, Michael Heike, G. Schuch, Timo Gaiser, Flot Aio Investigators, Thorsten Oliver Goetze, Helga Bernhard, Sebastian Belle, Nils Homann, Johannes Meiler, Hans-Georg Kopp, Nicole Prasnikar, Christian Teschendorf, Andreas Block, Michael Schenk, Volker Heinemann, Markus Moehler, Stefan Kasper, Claudia Pauligk, Kim Barbara Luley, Ralf Hofheinz, Harald Schmalenberg, Michael Kneba, Frank Kullmann, Wolf O. Bechstein, Jörg T. Hartmann, Uwe M. Martens, Martin Schuler, U. Lindig, Fuat Oduncu, Peter C. Thuss-Patience, Thomas Kraus, Gunnar Folprecht, Frank Mayer, Michael Koenigsmann, Elke Jäger, Wolfgang Fischbach, Stefan Mönig, Ludwig Fischer von Weikersthal, Martina Güntner, Karsten Schulmann

المصدر: The Lancet. 393:1948-1957

مصطلحات موضوعية: medicine.medical_specialty, education.field_of_study, Chemotherapy, business.industry, medicine.medical_treatment, Population, Medizin, General Medicine, Perioperative, 030204 cardiovascular system & hematology, Gastroenterology, Oxaliplatin, Capecitabine, 03 medical and health sciences, 0302 clinical medicine, Docetaxel, Fluorouracil, Internal medicine, Medicine, 030212 general & internal medicine, business, education, medicine.drug, Epirubicin

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bb9328f246b91519e1997e982c1bc7c
https://doi.org/10.1016/s0140-6736(18)32557-1

المؤلفون: Sebastian Bauer, Annette Reichardt, Jouni Junnila, Harri Sihto, Peter Reichardt, Raija Kallio, Bengt Nilsson, Mikael Eriksson, Marcus Schlemmer, Peter Hohenberger, Silke Cameron, Heikki Joensuu, Salah-Eddin Al-Batran, Aki Vehtari, Daniel Pink, Kirsten Sundby Hall, Joerg T. Hartmann, Eva Wardelmann

المساهمون: Clinicum, Translational Cancer Biology (TCB) Research Programme, Heikki Joensuu / Principal Investigator, Department of Oncology, Research Programs Unit, HUS Comprehensive Cancer Center

المصدر: JAMA Oncology. 3(5):602-609

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, RESECTION, Population, 3122 Cancers, Medizin, MESYLATE, PDGFRA, medicine.disease_cause, 03 medical and health sciences, Exon, 0302 clinical medicine, POOR-PROGNOSIS, Internal medicine, medicine, education, RECURRENCE, RISK, ta113, education.field_of_study, Mutation, FRENCH SARCOMA GROUP, GiST, business.industry, ORIGIN, Imatinib, medicine.disease, digestive system diseases, 3. Good health, DELETIONS, 030104 developmental biology, Imatinib mesylate, 030220 oncology & carcinogenesis, Cancer research, Sarcoma, business, medicine.drug, GIST

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3d13f0a88c70e9025c6f2a50ea14cbf
https://doi.org/10.1001/jamaoncol.2016.5751

المؤلفون: Peter Hohenberger, Peter Reichardt, Sebastian Bauer, Daniel Pink, Bernd Kasper, Stephan Richter, Thomas Brodowicz

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Medizin, Soft tissue, medicine.disease, 030218 nuclear medicine & medical imaging, Pazopanib, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Breast cancer, Paclitaxel, chemistry, 030220 oncology & carcinogenesis, Internal medicine, medicine, Angiosarcoma, Sarcoma, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b90b6b64ca9afba3352b301997773efd

المؤلفون: Sebastian Bauer, Salah-Eddin Al-Batran, Maarit Sarlomo-Rikala, Ronald P. DeMatteo, Daniel Pink, Jochen Schütte, Kirsten Sundby Hall, Mikael Eriksson, Giuliano Ramadori, Peter Hohenberger, Jörg T. Hartmann, Eva Wardelmann, Heikki Joensuu, Peter Reichardt, Justus Duyster, Karla V. Ballman, Marcus Schlemmer, Harri Sihto, M. Leinonen, Bengt Nilsson

المساهمون: Clinicum, Department of Oncology, Department of Pathology, Haartman Institute (-2014), Translational Cancer Biology (TCB) Research Programme, Heikki Joensuu / Principal Investigator

المصدر: Cancer
Cancer; 120(15), pp 2325-2333 (2014)

مصطلحات موضوعية: Male, Oncology, Cancer Research, medicine.medical_specialty, Gastrointestinal Stromal Tumors, education, 3122 Cancers, Medizin, gastrointestinal stromal tumor, imatinib, adjuvant therapy, predictive score, Antineoplastic Agents, Drug Administration Schedule, Piperazines, Risk Factors, Internal medicine, medicine, Adjuvant therapy, score, Humans, predictive, Stromal tumor, neoplasms, Framingham Risk Score, GiST, business.industry, Cancer, Imatinib, Original Articles, Middle Aged, medicine.disease, 3. Good health, Surgery, Pyrimidines, Chemotherapy, Adjuvant, Cancer and Oncology, Benzamides, Cohort, Imatinib Mesylate, Female, Sarcoma, Neoplasm Recurrence, Local, business, medicine.drug

وصف الملف: text/html

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4082ca8a22a80fc6bf149dec8fb958fc
https://doi.org/10.1002/cncr.28669

المؤلفون: Sebastian Bauer, Florian Grabellus, Peter Reichardt, E Bock, Daniel Pink, Mathias Hoiczyk, James Nagarajah, Martin Schuler, A. Pustowka, Susanne Grunewald, Annette Reichardt, Thomas Mühlenberg, Ralf A. Hilger, Max E. Scheulen, Marit Ahrens

المصدر: British Journal of Cancer

مصطلحات موضوعية: Oncology, Male, Cancer Research, Indoles, Medizin, Hydroxamic Acids, Tyrosine-kinase inhibitor, Piperazines, chemistry.chemical_compound, Antineoplastic Combined Chemotherapy Protocols, Gastrointestinal Neoplasms, GiST, LBH589, KIT, Middle Aged, targeted therapy, Benzamides, Imatinib Mesylate, Female, medicine.symptom, medicine.drug, GIST, Adult, medicine.medical_specialty, histonedeacetylase inhibitors, panobinostat, Maximum Tolerated Dose, medicine.drug_class, Nausea, Gastrointestinal Stromal Tumors, Antineoplastic Agents, Internal medicine, Panobinostat, medicine, Humans, Histone H3 acetylation, Adverse effect, neoplasms, Aged, business.industry, Imatinib, Histone Deacetylase Inhibitors, Imatinib mesylate, Pyrimidines, chemistry, Cancer research, Clinical Study, imatinib resistance, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a300eb851f80755434574259b663cdf
http://europepmc.org/articles/PMC3950855

المؤلفون: Heikki Joensuu, Kirsten Sundby Hall, Bengt Nilsson, Annette Reichardt, Marcus Schlemmer, Salah-Eddin Al-Batran, Peter Hohenberger, Jouni Junnila, Mikael Eriksson, Harri Sihto, Sebastian Bauer, Daniel Pink, Thor Alvegård, Eva Wardelmann, Joerg T. Hartmann, Peter Reichardt, Petri Bono, Giuliano Ramadori, Raija Kallio

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Gastrointestinal Stromal Tumors, medicine.medical_treatment, Medizin, Administration, Oral, Antineoplastic Agents, Disease-Free Survival, Drug Administration Schedule, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Humans, Medicine, Stromal tumor, Aged, Gastrointestinal Neoplasms, Chemotherapy, GiST, business.industry, Imatinib, Middle Aged, medicine.disease, 3. Good health, Surgery, Clinical trial, 030104 developmental biology, Imatinib mesylate, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Imatinib Mesylate, Female, Sarcoma, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7fb4844d970c78b821e6162eb220a65
https://www.ncbi.nlm.nih.gov/pubmed/26527782

المؤلفون: Giuliano Ramadori, Annette Reichardt, Daniel Pink, Salah-Eddin Al-Batran, Kirsten Sundby Hall, Raija Kallio, Justus Duyster, Petri Bono, Thor Alvegård, Bengt E. Nilsson, Peter Reichardt, Odd R. Monge, Eva Wardelmann, Sebastian Bauer, Mikael Eriksson, Jouni Junnila, Peter Hohenberger, Heikki Joensuu, Marcus Schlemmer

المصدر: Web of Science

مصطلحات موضوعية: 0303 health sciences, Cancer Research, Tumor histology, medicine.medical_specialty, Randomization, GiST, business.industry, medicine.medical_treatment, Medizin, Imatinib, 3. Good health, Surgery, 03 medical and health sciences, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Risk stratification, medicine, Overall survival, business, Adjuvant, 030304 developmental biology, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c21a24be6f5863599264c43c7de781b8
http://ascopubs.org/doi/abs/10.1200/jco.2015.33.15_suppl.10505

المؤلفون: Sebastian Bauer, J. C. Trent, Florence Duffaud, J.-Y. Blay, U. Bitz, Michael Montemurro, Hans Gelderblom, Daniel Pink, Jochen Schütte, Heikki Joensuu, Piotr Rutkowski

المصدر: European Journal of Cancer, 49(5), 1027-1031

مصطلحات موضوعية: Oncology, Male, Cancer Research, Indoles, Gastrointestinal stromal tumour, Medizin, Tyrosine kinase inhibitor, urologic and male genital diseases, Tyrosine-kinase inhibitor, Piperazines, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Sunitinib, Relapse, Gastrointestinal Neoplasms, Aged, 80 and over, 0303 health sciences, GiST, Progression, Middle Aged, Sorafenib, female genital diseases and pregnancy complications, 3. Good health, Treatment Outcome, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Benzamides, Disease Progression, Imatinib Mesylate, Salvage, Female, Tyrosine kinase, medicine.drug, GIST, Adult, Niacinamide, medicine.medical_specialty, medicine.drug_class, Gastrointestinal Stromal Tumors, Drug Administration Schedule, 03 medical and health sciences, Young Adult, Internal medicine, medicine, Humans, Pyrroles, neoplasms, Protein Kinase Inhibitors, 030304 developmental biology, Aged, Retrospective Studies, Salvage Therapy, Performance status, Dose-Response Relationship, Drug, business.industry, Phenylurea Compounds, Imatinib, Nilotinib, digestive system diseases, Surgery, Pyrimidines, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9c0c44f0b1528fe8da2540611b5a5fa
https://hdl.handle.net/1887/100095